Learn More
Invitrogen™ DR4 Monoclonal Antibody (DR-4-02), FITC

Description
This antibody recognizes an extracellular epitope of TRAIL-R1 (DR4), a human death receptor 4 expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumor-derived cell lines.
Specifications
Specifications
| Antigen | DR4 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | DR-4-02 |
| Concentration | 0.1 mg/mL |
| Conjugate | FITC |
| Formulation | PBS with 0.2% BSA and 15mM sodium azide; pH 7.4 |
| Gene | TNFRSF10A |
| Gene Accession No. | O00220 |
| Gene Alias | APO2; CD261; cytotoxic TRAIL receptor; death receptor 4; DR4; MGC9365; sCD261; soluble CD261; soluble TRAIL; sTRAIL; TNF receptor superfamily member 10a; TNF-related apoptosis-inducing ligand receptor 1; TNFRSF10A; TRAIL R1; TRAIL receptor 1; TRAILR1; TRAIL-R1; TRAILR-1; tumor necrosis factor receptor superfamily member 10A; tumor necrosis factor receptor superfamily member 10a variant 2; tumor necrosis factor receptor superfamily, member 10a |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.